Clinical Trials Directory

Trials / Completed

CompletedNCT03257605

A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly

Implementation of a Pharmacist-Led Pharmacogenomics Service for the Program of All-inclusive Care for the Elderly (PHARM-GENOME-PACE)

Status
Completed
Phase
Study type
Observational
Enrollment
296 (actual)
Sponsor
Tabula Rasa HealthCare · Industry
Sex
All
Age
55 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate and describe the feasibility of implementing a pharmacist-led pharmacogenomics service for the Program of All-inclusive Care for the Elderly (PACE), a community-based practice setting.

Detailed description

To determine if a pharmacogenomics (PGx) service can become a component of everyday practice, feasibility assessments are needed. While some researchers have begun to assess the feasibility of implementing PGx into pharmacy practice in community-based practice settings, none that we are aware have assessed such feasibility for the Program of All-inclusive Care for the Elderly (PACE). The primary objective of this feasibility study is to evaluate the processes that were involved in implementing a pharmacist-led PGx service for PACE and to describe process-related challenges and solutions associated with implementation. Secondary objectives include: describe pharmacists' roles in the implementation process; report aggregate PGx test results, including genetic variants and drug-gene interactions; and describe pharmacists' recommendations to personalize drug regimens for PACE participants and prescribers' acceptance of these recommendations.

Conditions

Timeline

Start date
2014-05-01
Primary completion
2016-06-01
Completion
2017-08-01
First posted
2017-08-22
Last updated
2017-08-22

Source: ClinicalTrials.gov record NCT03257605. Inclusion in this directory is not an endorsement.